Skip to content Skip to footer

Is ETT the New Revolution in Oligonucleotide Synthesis?

Introduction Oligonucleotide synthesis is no longer just a lab exercise — it’s a high-demand industrial process, powering therapeutics, diagnostics, and cutting-edge research. As the market grows, manufacturers are constantly seeking ways to improve yield, reduce cycle times, and ensure product quality. Enter ETT (5-Ethylthio-1H-tetrazole) — an activator that is quickly being recognized as a game-changer…

Read More